Thomas R Staab II's Net Worth
Thomas R Staab II's net worth is estimated to be at least $2,371,820.14 as of 11/08/2024. CoreStreet's estimation of Thomas R Staab II's net worth is based on their sale of stock and current holding of stock.
Thomas R Staab II is CFO at LENSAR Inc. They have executed at least 36 trades of stock as per SEC Form 4 filings. Their most recent trade was for 2,025 units of LNSR stock on 12/06/2022. Their biggest sale was on 06/19/2015 when they sold 16,375 units of BioCryst Pharmaceuticals Inc stock for $235,145.00. They typically trade 5 times per year.
Total value of insider buys:
- $6,399.00
Total value of insider sells:
- $2,365,421.14
Most recent insider trade:
- Dec. 6, 2022
Thomas R Staab II's Insider Trading History
LENSAR Inc | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|
Dec. 6, 2022 | CFO | 2,025 | $3.16 | Buy | $6,399.00 |
BioCryst Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|
May 17, 2019 | Insider | 9,750 | $7.65 | Sell | $74,587.50 |
May 15, 2019 | Insider | 11,750 | $7.81 | Sell | $91,767.50 |
May 13, 2019 | Insider | 19,500 | $7.70 | Sell | $150,150.00 |
May 9, 2019 | CFO | 9,750 | $7.63 | Sell | $74,392.50 |
May 6, 2019 | CFO | 9,000 | $7.75 | Sell | $69,750.00 |
May 2, 2019 | CFO | 7,750 | $7.30 | Sell | $56,575.00 |
April 4, 2019 | Insider | 7,500 | $8.81 | Sell | $66,075.00 |
Jan. 28, 2019 | CFO | 5,000 | $9.85 | Sell | $49,250.00 |
Dec. 4, 2018 | Insider | 3,922 | $9.45 | Sell | $37,062.90 |
Nov. 23, 2018 | Insider | 15,500 | $9.32 | Sell | $144,460.00 |
Nov. 20, 2018 | Insider | 11,198 | $8.67 | Sell | $97,086.66 |
Nov. 8, 2018 | Insider | 14,087 | $8.12 | Sell | $114,386.44 |
Nov. 5, 2018 | Insider | 215 | $8.00 | Sell | $1,720.00 |
Nov. 2, 2018 | CFO | 10,856 | $7.84 | Sell | $85,111.04 |
Oct. 19, 2018 | Insider | 3,150 | $7.45 | Sell | $23,467.50 |
Oct. 3, 2018 | Insider | 9,850 | $7.24 | Sell | $71,314.00 |
March 20, 2017 | CFO | 3,250 | $9.20 | Sell | $29,900.00 |
March 10, 2017 | Insider | 3,250 | $9.06 | Sell | $29,445.00 |
March 8, 2017 | Insider | 6,500 | $8.43 | Sell | $54,795.00 |
March 6, 2017 | Insider | 3,250 | $7.90 | Sell | $25,675.00 |
Dec. 19, 2016 | Insider | 3,250 | $7.45 | Sell | $24,212.50 |
Aug. 12, 2016 | Insider | 5,864 | $5.18 | Sell | $30,375.52 |
Aug. 9, 2016 | Insider | 14,577 | $4.43 | Sell | $64,576.11 |
Dec. 21, 2015 | CFO | 3,052 | $10.86 | Sell | $33,144.72 |
Dec. 17, 2015 | CFO | 3,000 | $10.49 | Sell | $31,470.00 |
July 20, 2015 | CFO | 3,500 | $16.50 | Sell | $57,750.00 |
June 22, 2015 | CFO | 3,750 | $16.00 | Sell | $60,000.00 |
June 19, 2015 | CFO | 16,375 | $14.36 | Sell | $235,145.00 |
June 5, 2015 | CFO | 6,000 | $12.75 | Sell | $76,500.00 |
May 18, 2015 | CFO | 3,000 | $11.00 | Sell | $33,000.00 |
Dec. 29, 2014 | CFO | 9,500 | $12.56 | Sell | $119,320.00 |
Aug. 27, 2014 | CFO | 10,000 | $13.58 | Sell | $135,800.00 |
July 1, 2014 | CFO | 3,125 | $13.00 | Sell | $40,625.00 |
June 23, 2014 | CFO | 3,125 | $12.49 | Sell | $39,031.25 |
June 17, 2014 | CFO | 3,125 | $12.00 | Sell | $37,500.00 |